Thursday 25th March 2010
Royal Society of Medicine, London, UK

With the emergence in recent years of several novel molecules with putative efficacy in cancer management, the search for biomarkers of response which can potentially be used in their clinical evaluation is extremely topical. The objective of this conference is to provide a state-of-the-art overview of biomarkers in cancer chemotherapy and chemoprevention. It is aimed at researchers (basic scientists and clinicians) engaged in translational cancer pharmacology and new anticancer drug development in academia, industry and hospitals.

Register on line here.

Transcriptional control mechanisms and how they can be subverted in cancer are well studied. In contrast, until recently, very little was known about translational regulation and its importance in cancer.

This international meeting will update delegates on what is now a rapidly expanding field encompassing micro RNAs and mRNA translational control mechanisms with a particular focus on how this is altered in cancer.